JPS5535019A - Carbostyryl derivative - Google Patents

Carbostyryl derivative

Info

Publication number
JPS5535019A
JPS5535019A JP10786978A JP10786978A JPS5535019A JP S5535019 A JPS5535019 A JP S5535019A JP 10786978 A JP10786978 A JP 10786978A JP 10786978 A JP10786978 A JP 10786978A JP S5535019 A JPS5535019 A JP S5535019A
Authority
JP
Japan
Prior art keywords
carbostyryl
antiphlogistic
dehydrohalogenating
derivative
agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP10786978A
Other languages
English (en)
Other versions
JPS6155514B2 (ja
Inventor
Takao Nishi
Kazuyuki Nakagawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Otsuka Pharmaceutical Co Ltd
Original Assignee
Otsuka Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=14470137&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=JPS5535019(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Otsuka Pharmaceutical Co Ltd filed Critical Otsuka Pharmaceutical Co Ltd
Priority to JP10786978A priority Critical patent/JPS5535019A/ja
Priority to CA000334272A priority patent/CA1139761A/en
Priority to DE19792934747 priority patent/DE2934747A1/de
Priority to US06/070,710 priority patent/US4277479A/en
Priority to AR277883A priority patent/AR229342A1/es
Priority to AU50397/79A priority patent/AU538410B2/en
Priority to PH22976A priority patent/PH18452A/en
Priority to NLAANVRAGE7906523,A priority patent/NL183888C/xx
Priority to SU792804457A priority patent/SU1064868A3/ru
Priority to DK363179A priority patent/DK158788C/da
Priority to FI792699A priority patent/FI68398C/fi
Priority to BE0/196976A priority patent/BE878548A/xx
Priority to MX798357U priority patent/MX6749E/es
Priority to NO792829A priority patent/NO153177C/no
Priority to ES483792A priority patent/ES483792A1/es
Priority to FR7921869A priority patent/FR2434809A1/fr
Priority to CH792079A priority patent/CH641799A5/de
Priority to ZA00794627A priority patent/ZA794627B/xx
Priority to SE7907236A priority patent/SE432252B/sv
Priority to IT68748/79A priority patent/IT1119929B/it
Priority to PT70136A priority patent/PT70136A/pt
Priority to GB7930520A priority patent/GB2033893B/en
Priority to AT0584579A priority patent/AT364363B/de
Publication of JPS5535019A publication Critical patent/JPS5535019A/ja
Publication of JPS6155514B2 publication Critical patent/JPS6155514B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
JP10786978A 1978-09-01 1978-09-01 Carbostyryl derivative Granted JPS5535019A (en)

Priority Applications (23)

Application Number Priority Date Filing Date Title
JP10786978A JPS5535019A (en) 1978-09-01 1978-09-01 Carbostyryl derivative
CA000334272A CA1139761A (en) 1978-09-01 1979-08-22 Tetrazolylalkoxycarbostyril derivatives and process for producing the same
DE19792934747 DE2934747A1 (de) 1978-09-01 1979-08-28 Tetrazolylalkoxycarbostyrilderivate, verfahren zu deren herstellung und arzneimittel, welche diese enthalten
PH22976A PH18452A (en) 1978-09-01 1979-08-29 Novel tetrayolylakoxy carbostyril derivatives
AR277883A AR229342A1 (es) 1978-09-01 1979-08-29 Procedimiento para obtener derivados de(5-tetrazolilalquilenoxi)-carboestirilo o 3,4-dihidrocarboestirilo y procedimiento para preparar 5-haloalquilen-tetrazol de aplicacion exclusiva como reactivo en dicho procedimiento
US06/070,710 US4277479A (en) 1978-09-01 1979-08-29 Tetrazolylalkoxycarbostyril derivatives and pharmaceutical compositions containing them
AU50397/79A AU538410B2 (en) 1978-09-01 1979-08-29 Tetrazolyl alkoxy carbostyril derivatives
NLAANVRAGE7906523,A NL183888C (nl) 1978-09-01 1979-08-30 Carbostyrilderivaat met een remmende werking op de aggregatie van bloedplaatjes, werkwijze ter bereiding van deze derivaten, farmaceutisch preparaat dat een dergelijk derivaat bevat en werkwijze ter bereiding van dergelijke farmaceutische preparaten.
SU792804457A SU1064868A3 (ru) 1978-09-01 1979-08-30 Способ получени тетразолилалкоксикарбостирилов
DK363179A DK158788C (da) 1978-09-01 1979-08-30 Analogifremgangsmaade til fremstilling af tetrazolylalkoxycarbostyrilderivater
FI792699A FI68398C (fi) 1978-09-01 1979-08-30 Foerfarande foer framstaellning av nya terapeutiskt anvaendbara tetrazolylalkoxikarbostyrilderivat
PT70136A PT70136A (en) 1978-09-01 1979-08-31 Novel tetrazolylalkoxycarbostyril derivatives and process for producing the same
SE7907236A SE432252B (sv) 1978-09-01 1979-08-31 Tetrazolyl-alkoxi-karbostyrilderivat
BE0/196976A BE878548A (fr) 1978-09-01 1979-08-31 Nouveaux derives de tetrazolylalcoxycarbostyrile, procede pour leur preparation et leurs applications en therapeutique
NO792829A NO153177C (no) 1978-09-01 1979-08-31 Analogifremgangsmaate for fremstilling av farmakologisk aktive tetrazolylalkoksy-karbostyrilderivater.
ES483792A ES483792A1 (es) 1978-09-01 1979-08-31 Un procedimiento para la preparacion de derivados de tetra- zolilalcoxicarbostirilo.
FR7921869A FR2434809A1 (fr) 1978-09-01 1979-08-31 Nouveaux derives de tetrazolylalcoxycarbostyrile, procede pour leur preparation et leurs applications en therapeutique
CH792079A CH641799A5 (de) 1978-09-01 1979-08-31 Tetrazolylalkoxycarbostyrilderivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel.
ZA00794627A ZA794627B (en) 1978-09-01 1979-08-31 Novel tetrazolylalkoxycarbostyril derivatives and process for producing the same
MX798357U MX6749E (es) 1978-09-01 1979-08-31 Procedimiento para la preparacion de derivados de tetrazolilalcoxicarboestirilo
IT68748/79A IT1119929B (it) 1978-09-01 1979-08-31 Derivati del tetrazolil alcossi carbostirile e procedimento per la loro fabbricazione
AT0584579A AT364363B (de) 1978-09-01 1979-09-03 Verfahren zum herstellen neuer tetrazolylalkoxycarbostyrilderivate
GB7930520A GB2033893B (en) 1978-09-01 1979-09-03 Tetrazolylalkoxycarbostyril derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP10786978A JPS5535019A (en) 1978-09-01 1978-09-01 Carbostyryl derivative

Publications (2)

Publication Number Publication Date
JPS5535019A true JPS5535019A (en) 1980-03-11
JPS6155514B2 JPS6155514B2 (ja) 1986-11-28

Family

ID=14470137

Family Applications (1)

Application Number Title Priority Date Filing Date
JP10786978A Granted JPS5535019A (en) 1978-09-01 1978-09-01 Carbostyryl derivative

Country Status (23)

Country Link
US (1) US4277479A (ja)
JP (1) JPS5535019A (ja)
AR (1) AR229342A1 (ja)
AT (1) AT364363B (ja)
AU (1) AU538410B2 (ja)
BE (1) BE878548A (ja)
CA (1) CA1139761A (ja)
CH (1) CH641799A5 (ja)
DE (1) DE2934747A1 (ja)
DK (1) DK158788C (ja)
ES (1) ES483792A1 (ja)
FI (1) FI68398C (ja)
FR (1) FR2434809A1 (ja)
GB (1) GB2033893B (ja)
IT (1) IT1119929B (ja)
MX (1) MX6749E (ja)
NL (1) NL183888C (ja)
NO (1) NO153177C (ja)
PH (1) PH18452A (ja)
PT (1) PT70136A (ja)
SE (1) SE432252B (ja)
SU (1) SU1064868A3 (ja)
ZA (1) ZA794627B (ja)

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57156469A (en) * 1981-03-19 1982-09-27 Otsuka Pharmaceut Co Ltd Preparation of tetrazole derivative
JPS57183761A (en) * 1981-04-30 1982-11-12 Otsuka Pharmaceut Co Ltd Carbostyril derivative
JPS5859980A (ja) * 1981-10-05 1983-04-09 Otsuka Pharmaceut Co Ltd カルボスチリル誘導体
JPS5877880A (ja) * 1981-11-05 1983-05-11 Otsuka Pharmaceut Co Ltd テトラゾ−ル誘導体
JPS6345220A (ja) * 1986-04-02 1988-02-26 Otsuka Pharmaceut Co Ltd 血小板粘着抑制剤
JPS646271A (en) * 1986-04-02 1989-01-10 Otsuka Pharma Co Ltd Carbostyril derivative
JPH0776521A (ja) * 1993-09-07 1995-03-20 Otsuka Pharmaceut Co Ltd 気道炎症抑制剤
JP2006518732A (ja) * 2003-02-25 2006-08-17 大塚製薬株式会社 ＰＴＥＮ阻害剤またはＭａｘｉ−Ｋチャンネルオープナー
WO2008111662A1 (en) 2007-03-09 2008-09-18 Otsuka Pharmaceutical Co., Ltd. A medicament for treating chronic obstructive pulmonary disease
WO2008123592A1 (en) 2007-03-30 2008-10-16 Otsuka Pharmaceutical Co., Ltd. A medicament for treating schizophrenia comprising cilostazol
US7825251B2 (en) 2001-05-02 2010-11-02 Otsuka Pharmaceutical Co., Ltd. Process for producing carbostyril derivatives
JP2012510502A (ja) * 2008-12-02 2012-05-10 カーディオリンクス・アーゲー 血管性及び代謝性疾患の処置のためのシロスタゾールの硝酸エステル誘導体
EP2937085A1 (en) 2007-05-22 2015-10-28 Otsuka Pharmaceutical Co., Ltd. A medicament comprising a carbostyril derivative and donezepil for treating alzheimer's disease

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3225169A1 (de) * 1982-07-06 1984-01-12 Basf Ag, 6700 Ludwigshafen Chinolinderivate, verfahren zu ihrer herstellung, diese enthaltende mikrobizide und ihre verwendung zur bekaempfung von pilzen
US4803162A (en) * 1984-05-15 1989-02-07 Fluorodiagnostic Limited Partners Composition, article and process for detecting a microorganism
ES8608874A1 (es) * 1984-05-29 1986-09-01 Pfizer Un procedimiento para la preparacion de una 2-(1h)-quinolona
GB8529362D0 (en) * 1985-11-28 1986-01-02 Pfizer Ltd Quinolone cardiac stimulants
KR940000785B1 (ko) * 1986-04-02 1994-01-31 오오쓰까세이야꾸 가부시끼가이샤 카르보스티릴 유도체 및 그의 염의 제조 방법
DK167187A (da) * 1986-04-02 1987-10-03 Otsuka Pharma Co Ltd Carbostyrilderivater og salte deraf, fremgangsmaade til fremstilling af saadanne forbindelser og laegemiddel indeholdende disse
JP2753622B2 (ja) 1988-05-02 1998-05-20 大塚製薬株式会社 カルボスチリル誘導体
US5064837A (en) * 1989-11-13 1991-11-12 Schering Corporation 3-substituted-1-aryl-2(h)-quinolones and their pharmaceutical compositions
JPH07100648B1 (ja) * 1990-01-08 1995-11-01
TW201305B (ja) * 1991-04-03 1993-03-01 Otsuka Pharma Co Ltd
WO1993004042A1 (fr) * 1991-08-23 1993-03-04 Otsuka Pharmaceutical Co., Ltd. Derive de carbostyrile et antiagregant plaquettaire
US6187790B1 (en) 1999-03-04 2001-02-13 Neal R. Cutler Use of cilostazol for treatment of sexual dysfunction
US20030045547A1 (en) * 2001-05-02 2003-03-06 Shinji Aki Process for producing carbostyril derivatives
JP4060523B2 (ja) * 1999-11-24 2008-03-12 大塚製薬株式会社 カルボスチリル誘導体の製造法
US6515128B2 (en) 2000-03-20 2003-02-04 Teva Pharmaceutical Industries Ltd. Processes for preparing cilostazol
US6825214B2 (en) 2000-08-14 2004-11-30 Teva Pharmaceutical Industries, Ltd. Substantially pure cilostazol and processes for making same
AU2001250892A1 (en) 2000-03-20 2001-10-03 Teva Pharmaceutical Industries Ltd. Processes for preparing 6-hydroxy-3,4-dihydroquinolinone, cilostazol and n-(4-methoxyphenyl)-3-chloropropionamide
JP3845059B2 (ja) * 2000-08-14 2006-11-15 テバ ファーマシューティカル インダストリーズ リミティド シロスタゾールの製造方法
US6458804B1 (en) * 2001-01-26 2002-10-01 R.T. Alamo Venturesi, Llc Methods for the treatment of central nervous system disorders in certain patient groups
US6451813B1 (en) 2001-01-26 2002-09-17 R. T. Alamo Ventures I, Llc Treatment of gastroparesis in certain patient groups
US7399864B2 (en) * 2001-05-02 2008-07-15 Otsuka Pharmaceutical Co., Ltd. Process for producing carbostyril derivatives
JP2003063965A (ja) * 2001-06-13 2003-03-05 Otsuka Pharmaceut Factory Inc 注射用シロスタゾール水性製剤
US6596871B2 (en) * 2001-06-29 2003-07-22 Grayson Walker Stowell Polymorphic forms of 6-[4-(1-cyclohexyl-1h-tetraol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone
US6660864B2 (en) * 2001-06-29 2003-12-09 Grayson Walker Stowell Polymorphic forms of 6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone
US6531603B1 (en) * 2001-06-29 2003-03-11 Grayson Walker Stowell Polymorphic forms of 6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone
WO2003002529A2 (en) * 2001-06-29 2003-01-09 Aaipharma, Inc. Polymorphic forms of 6-[4-(1-cyclohexyl-1h-tetrazol-5-yl)butoxy]-3, 4-dihydro-2(1h)-quinolinone
US6573382B2 (en) * 2001-06-29 2003-06-03 Grayson Walker Stowell Polymorphic forms of 6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone
US6388080B1 (en) 2001-06-29 2002-05-14 Grayson Walker Stowell Polymorphic forms of 6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone
WO2003002121A1 (en) * 2001-06-29 2003-01-09 Aaipharma, Inc. Polymorphic forms of 6-[4-(1-cyclohexyl-1h-tetrazol-5-yl)butoxy]-3, 4-dihydro-2(1h)-quinolinone
US6657061B2 (en) * 2001-06-29 2003-12-02 Grayson Walker Stowell Polymorphic forms of 6-[4-1(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone
ATE496907T1 (de) * 2002-09-10 2011-02-15 Otsuka Pharma Co Ltd Verfahren zur herstellung von cilostazol
US6743806B2 (en) * 2002-10-23 2004-06-01 Otsuka Pharmaceutical Company, Limited Active oxygen scavenger
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
ITMI20031670A1 (it) * 2003-08-26 2005-02-27 Dinamite Dipharma S P A In Forma A Bbreviata Diph Processo per la preparazione di cilostazolo e di suoi intermedi.
US7524960B2 (en) * 2004-03-16 2009-04-28 Chemagis Ltd. Highly pure cilostazol and an improved process for obtaining same
US20050255155A1 (en) * 2004-05-11 2005-11-17 Glenmark Pharmaceuticals Limited Modified release cilostazol compositions
WO2006030301A1 (en) * 2004-09-17 2006-03-23 Ranbaxy Laboratories Limited Cilostazol- containing pharmaceutical composition based on particles of less than 50 micrometers
CN100462360C (zh) * 2005-08-15 2009-02-18 上海立科药物化学有限公司 N-环己基-5-(4-氯丁基)-1h-四氮唑的合成方法
TWI372053B (en) * 2005-09-15 2012-09-11 Otsuka Pharma Co Ltd Combination drug
US20070105898A1 (en) * 2005-11-09 2007-05-10 Apotex Pharmachem Inc. Process for the production of cilostazol
US8349817B2 (en) 2007-04-25 2013-01-08 Concert Pharmaceuticals, Inc. Analogues of cilostazol
US20090042842A1 (en) * 2007-04-25 2009-02-12 Concert Pharmaceuticals, Inc. Analogues of cilostazol
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
MX354786B (es) 2007-06-04 2018-03-21 Synergy Pharmaceuticals Inc Agonistas de guanilato ciclasa utiles para el tratamiento de trastornos gastrointestinales, inflamacion, cancer y otros trastornos.
CA2726917C (en) 2008-06-04 2018-06-26 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
WO2010009319A2 (en) 2008-07-16 2010-01-21 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
WO2011158110A2 (en) 2010-04-28 2011-12-22 Nuformix Limited Cilostazol cocrystals and compositions
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
US9580471B2 (en) 2011-03-01 2017-02-28 Synergy Pharmaceuticals, Inc. Process of preparing guanylate cyclase C agonists
US9545446B2 (en) 2013-02-25 2017-01-17 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase and their uses
EP2970384A1 (en) 2013-03-15 2016-01-20 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
WO2014151200A2 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Compositions useful for the treatment of gastrointestinal disorders
JP6606491B2 (ja) 2013-06-05 2019-11-13 シナジー ファーマシューティカルズ インコーポレイテッド グアニル酸シクラーゼｃの超高純度アゴニスト、その作成および使用方法
JP6694385B2 (ja) 2013-08-09 2020-05-13 アーデリクス，インコーポレーテッド リン酸塩輸送阻害のための化合物及び方法
WO2020237096A1 (en) 2019-05-21 2020-11-26 Ardelyx, Inc. Combination for lowering serum phosphate in a patient

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2470084A (en) * 1945-09-25 1949-05-17 Bilhuber Inc E Substituted alpha-halogen alkyl tetrazoles and process for obtaining the same
US2470085A (en) * 1947-03-07 1949-05-17 Bilhuber Inc E Substituted amino alkyl tetrazoles
AR207554A1 (es) * 1972-12-02 1976-10-15 Otsuka Pharma Co Ltd Procedimiento para producir derivados de 3-alquil-5-((3,4-dihidro-5-carbostiril)oximetil)-oxazolidinona-(2)
JPS5310986B2 (ja) * 1974-02-05 1978-04-18
JPS5310989B2 (ja) * 1974-04-25 1978-04-18
FI59246C (fi) * 1974-06-24 1981-07-10 Otsuka Pharma Co Ltd Foerfarande foer framstaellning av benscykloamidderivat anvaendbara vid trombos- och emboliterapin
FI58329C (fi) * 1974-11-08 1981-01-12 Otsuka Pharma Co Ltd Foerfarande foer framstaellning av i 8-staellning substituerade 5-(3'-alkylamino-2'-hydroxi)propoxi-3,4-dihydrokarbostyrilderivat
US4129565A (en) * 1975-07-11 1978-12-12 Nisshin Flour Milling Co., Ltd. Isocarbostyril derivatives
US4210753A (en) * 1976-03-17 1980-07-01 Otsuka Pharmaceutical Co., Ltd. Carbostyril compounds
JPS52116482A (en) * 1976-03-24 1977-09-29 Otsuka Pharmaceut Co Ltd Carbostyril derivatives and its preparation
JPS5430183A (en) * 1977-08-10 1979-03-06 Otsuka Pharmaceut Co Ltd 3,4-dihydrocarbostyril derivative

Cited By (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57156469A (en) * 1981-03-19 1982-09-27 Otsuka Pharmaceut Co Ltd Preparation of tetrazole derivative
JPH0227346B2 (ja) * 1981-03-19 1990-06-15 Otsuka Pharma Co Ltd
JPH0114911B2 (ja) * 1981-04-30 1989-03-14 Otsuka Pharma Co Ltd
JPS57183761A (en) * 1981-04-30 1982-11-12 Otsuka Pharmaceut Co Ltd Carbostyril derivative
JPS5859980A (ja) * 1981-10-05 1983-04-09 Otsuka Pharmaceut Co Ltd カルボスチリル誘導体
JPS64397B2 (ja) * 1981-10-05 1989-01-06 Otsuka Pharma Co Ltd
JPS5877880A (ja) * 1981-11-05 1983-05-11 Otsuka Pharmaceut Co Ltd テトラゾ−ル誘導体
JPS6345220A (ja) * 1986-04-02 1988-02-26 Otsuka Pharmaceut Co Ltd 血小板粘着抑制剤
JPS646271A (en) * 1986-04-02 1989-01-10 Otsuka Pharma Co Ltd Carbostyril derivative
JPH0776521A (ja) * 1993-09-07 1995-03-20 Otsuka Pharmaceut Co Ltd 気道炎症抑制剤
US7825251B2 (en) 2001-05-02 2010-11-02 Otsuka Pharmaceutical Co., Ltd. Process for producing carbostyril derivatives
JP2006518732A (ja) * 2003-02-25 2006-08-17 大塚製薬株式会社 ＰＴＥＮ阻害剤またはＭａｘｉ−Ｋチャンネルオープナー
WO2008111662A1 (en) 2007-03-09 2008-09-18 Otsuka Pharmaceutical Co., Ltd. A medicament for treating chronic obstructive pulmonary disease
WO2008123592A1 (en) 2007-03-30 2008-10-16 Otsuka Pharmaceutical Co., Ltd. A medicament for treating schizophrenia comprising cilostazol
EP2937085A1 (en) 2007-05-22 2015-10-28 Otsuka Pharmaceutical Co., Ltd. A medicament comprising a carbostyril derivative and donezepil for treating alzheimer's disease
JP2012510502A (ja) * 2008-12-02 2012-05-10 カーディオリンクス・アーゲー 血管性及び代謝性疾患の処置のためのシロスタゾールの硝酸エステル誘導体

Also Published As

Publication number Publication date
IT7968748A0 (it) 1979-08-31
FI68398B (fi) 1985-05-31
NO792829L (no) 1980-03-04
AU5039779A (en) 1980-03-06
JPS6155514B2 (ja) 1986-11-28
GB2033893A (en) 1980-05-29
NO153177C (no) 1986-01-29
FI792699A (fi) 1980-03-02
PH18452A (en) 1985-07-18
PT70136A (en) 1979-09-01
SE7907236L (sv) 1980-03-02
ZA794627B (en) 1980-08-27
NL7906523A (nl) 1980-03-04
CA1139761A (en) 1983-01-18
DK158788C (da) 1990-12-10
CH641799A5 (de) 1984-03-15
MX6749E (es) 1986-06-25
NO153177B (no) 1985-10-21
GB2033893B (en) 1982-12-01
FI68398C (fi) 1985-09-10
NL183888C (nl) 1989-02-16
AR229342A1 (es) 1983-07-29
DE2934747A1 (de) 1980-03-13
DK363179A (da) 1980-03-02
ES483792A1 (es) 1980-09-01
SU1064868A3 (ru) 1983-12-30
FR2434809B1 (ja) 1982-09-17
DE2934747C2 (ja) 1988-01-28
ATA584579A (de) 1981-03-15
AU538410B2 (en) 1984-08-16
DK158788B (da) 1990-07-16
FR2434809A1 (fr) 1980-03-28
US4277479A (en) 1981-07-07
SE432252B (sv) 1984-03-26
IT1119929B (it) 1986-03-19
AT364363B (de) 1981-10-12
BE878548A (fr) 1979-12-17

Similar Documents

Publication Publication Date Title
JPS5535019A (en) Carbostyryl derivative
AU527516B2 (en) (d1)-16-phenoxy-and 16-substituted phenoxy-9-keto prostatrienoic acid derivatives
AU4605579A (en) Process for the manufacture of oxygen-containing carbon compounds from synthesis gas
EG13622A (en) Process for the preparation of herbicidally active compounds containing phosphorus-carbon-nitrogen bond
JO992B1 (en) A new class of N-phenyl derivatives 1-3-oxazolidine 2-4- debt has a fungicide effect and a way to prepare these compounds
GB1364218A (en) N-alkoxy-carbonyl- or n-alkylthiocarbonyl-2-/2 -thienyl/-benzimi dazoles a process for their preparation and their use as fungi cides
ATE16556T1 (de) Insektizide zusammensetzung, ihre herstellung und ihre verwendung.
EG15180A (en) Heterocyclic ethers or thioether linkage containing urea compounds,process for producing same and insecticides containing said compounds
JPS5522667A (en) Manufacture of 66chlorooalphaamethylcarbazoll 22acetic acid
EG13684A (en) Chloracetanilides,a process for the production of these compounds and also herbicidal agents containing them
JPS5579370A (en) Carbostyril derivative
JPS5535018A (en) Alkaneamide derivative
JPS5549319A (en) Remedy for suppression of blood platelet-agglutination
JPS56122366A (en) Tetrazole derivative
JPS54160345A (en) O,o-dialkyl-s-(fluorobenzyl)thiophosphate and fungicide comprising it
ZA791766B (en) Process for the preparation of benzothiazolyl sulphenic acid morpholide
JPS554322A (en) 2-phenyl-substituted-1-phthalazone derivative
JPS5579371A (en) Carbostyril derivative
FR2419287A2 (fr) Bis-(a,a,a-trifluoro-p-tolyl)-1,5-pentadiene-1,4-one-3- (tetra-hydro-1,4,5,6-pyrimidinyl-2)-hydrazones utiles comme insecticides
ZA791566B (en) Process for the manufacture of oxygen-containing carbon compounds from synthesis gas
JPS57106671A (en) Urazole derivative and its preparation
JPS56122365A (en) Tetrazole derivative
JPS56100777A (en) Sulfide compound and its preparation
JPS6440480A (en) Novel tricyclic azole derivative, its production and agricultural and horticultural fungicide containing said derivative as active component
JPS54157577A (en) Insecticide